Breast cell line dose response to target inhibition measured by high throughput microscopy - Dataset (ID:20136)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | Drug Concentration | Conc Units | Timepoint | Timepoint Units | Measured pERK (Alexa 488) | Measured p-Rb (Alexa 568) | Alexa Fluor 647 | Measured p-Akt/p-4EBP1/p-S6 (Alexa 647) | Image |
---|---|---|---|---|---|---|---|---|---|---|
GSK1059615 | AU565 | 3.16 | nM | 6 | hr | 218.51 | 54.15 | p-Akt | 24.23 | |
GSK1059615 | AU565 | 3.16 | nM | 24 | hr | 458.06 | 113.08 | p-Akt | 91.73 | |
MK2206 | AU565 | 3.16 | nM | 6 | hr | 255.60 | 70.38 | p-Akt | 22.59 | |
MK2206 | AU565 | 3.16 | nM | 24 | hr | 384.01 | 117.27 | p-Akt | 62.56 | |
Triciribine | AU565 | 3.16 | nM | 6 | hr | 205.62 | 54.24 | p-Akt | 19.22 | |
Triciribine | AU565 | 3.16 | nM | 24 | hr | 469.42 | 121.81 | p-Akt | 100.82 | |
Dactolisib | AU565 | 3.16 | nM | 6 | hr | 259.31 | 60.60 | p-Akt | 24.45 | |
Dactolisib | AU565 | 3.16 | nM | 24 | hr | 451.27 | 106.53 | p-Akt | 105.91 | |
Gefitinib | HCC1954 | 3.16 | nM | 6 | hr | 285.82 | 61.71 | p-Akt | 30.33 | |
Gefitinib | HCC1954 | 3.16 | nM | 24 | hr | 289.89 | 119.71 | p-Akt | 80.84 | |
Torkinib | HCC1954 | 0.422 | nM | 6 | hr | 213.03 | 46.19 | p-Akt | 24.57 | |
Torkinib | HCC1954 | 0.422 | nM | 24 | hr | 275.88 | 108.45 | p-Akt | 62.94 | |
GSK1059615 | HCC1954 | 3.16 | nM | 6 | hr | 251.10 | 72.21 | p-Akt | 31.16 | |
GSK1059615 | HCC1954 | 3.16 | nM | 24 | hr | 310.37 | 108.43 | p-Akt | 68.72 | |
MK2206 | HCC1954 | 3.16 | nM | 6 | hr | 293.11 | 80.61 | p-Akt | 31.92 | |
MK2206 | HCC1954 | 3.16 | nM | 24 | hr | 274.49 | 113.08 | p-Akt | 59.52 | |
Triciribine | HCC1954 | 3.16 | nM | 6 | hr | 237.48 | 78.12 | p-Akt | 40.18 | |
Triciribine | HCC1954 | 3.16 | nM | 24 | hr | 300.93 | 100.97 | p-Akt | 59.45 | |
Dactolisib | HCC1954 | 3.16 | nM | 6 | hr | 218.96 | 75.61 | p-Akt | 41.58 | |
Dactolisib | HCC1954 | 3.16 | nM | 24 | hr | 294.20 | 99.05 | p-Akt | 76.79 | |
Gefitinib | MCF 10A | 3.16 | nM | 6 | hr | 471.10 | 159.36 | p-Akt | 45.78 | |
Gefitinib | MCF 10A | 3.16 | nM | 24 | hr | 306.15 | 127.83 | p-Akt | 46.77 | |
Torkinib | MCF 10A | 0.422 | nM | 6 | hr | 423.90 | 157.64 | p-Akt | 44.17 | |
Torkinib | MCF 10A | 0.422 | nM | 24 | hr | 369.53 | 130.31 | p-Akt | 47.72 | |
GSK1059615 | MCF 10A | 3.16 | nM | 6 | hr | 402.45 | 167.07 | p-Akt | 45.00 |